Your browser doesn't support javascript.
loading
SARS-CoV-2 Neutralization with BNT162b2 Vaccine Dose 3.
Falsey, Ann R; Frenck, Robert W; Walsh, Edward E; Kitchin, Nicholas; Absalon, Judith; Gurtman, Alejandra; Lockhart, Stephen; Bailey, Ruth; Swanson, Kena A; Xu, Xia; Koury, Kenneth; Kalina, Warren; Cooper, David; Zou, Jing; Xie, Xuping; Xia, Hongjie; Türeci, Özlem; Lagkadinou, Eleni; Tompkins, Kristin R; Shi, Pei-Yong; Jansen, Kathrin U; Sahin, Ugur; Dormitzer, Philip R; Gruber, William C.
Afiliação
  • Falsey AR; University of Rochester, Rochester, NY.
  • Frenck RW; Cincinnati Children's Hospital, Cincinnati, OH.
  • Walsh EE; University of Rochester, Rochester, NY.
  • Kitchin N; Pfizer Vaccine Research and Development, Hurley, United Kingdom nicholas.kitchin@pfizer.com.
  • Absalon J; Pfizer Vaccine Research and Development, Pearl River, NY.
  • Gurtman A; Pfizer Vaccine Research and Development, Pearl River, NY.
  • Lockhart S; Pfizer Vaccine Research and Development, Hurley, United Kingdom.
  • Bailey R; Pfizer Vaccine Research and Development, Hurley, United Kingdom.
  • Swanson KA; Pfizer Vaccine Research and Development, Pearl River, NY.
  • Xu X; Pfizer Vaccine Research and Development, Collegeville, PA.
  • Koury K; Pfizer Vaccine Research and Development, Pearl River, NY.
  • Kalina W; Pfizer Vaccine Research and Development, Pearl River, NY.
  • Cooper D; Pfizer Vaccine Research and Development, Pearl River, NY.
  • Zou J; University of Texas Medical Branch, Galveston, TX.
  • Xie X; University of Texas Medical Branch, Galveston, TX.
  • Xia H; University of Texas Medical Branch, Galveston, TX.
  • Türeci Ö; BioNTech, Mainz, Germany.
  • Lagkadinou E; BioNTech, Mainz, Germany.
  • Tompkins KR; Pfizer Vaccine Research and Development, Pearl River, NY.
  • Shi PY; University of Texas Medical Branch, Galveston, TX.
  • Jansen KU; Pfizer Vaccine Research and Development, Pearl River, NY.
  • Sahin U; BioNTech, Mainz, Germany.
  • Dormitzer PR; Pfizer Vaccine Research and Development, Pearl River, NY.
  • Gruber WC; Pfizer Vaccine Research and Development, Pearl River, NY.
N Engl J Med ; 385(17): 1627-1629, 2021 10 21.
Article em En | MEDLINE | ID: mdl-34525276
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunização Secundária / Anticorpos Neutralizantes / Imunogenicidade da Vacina / Vacinas contra COVID-19 / SARS-CoV-2 / COVID-19 Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunização Secundária / Anticorpos Neutralizantes / Imunogenicidade da Vacina / Vacinas contra COVID-19 / SARS-CoV-2 / COVID-19 Idioma: En Ano de publicação: 2021 Tipo de documento: Article